Beijing Tide Pharmaceutical Co., Ltd clinical trials

Acquired by Sino Biopharmaceutical Limited

The registry lists 14 studies whose lead sponsor is Beijing Tide Pharmaceutical Co., Ltd. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 22, 2026.

Studies

Recruiting first, then most recently updated. Showing 14 of 14. All Sino Biopharmaceutical Limited studies →

• Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)RecruitingNCT07543796Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07464912Phase 3

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• Phase I Study of CPD704 Inhalation Suspension in Healthy SubjectsRecruitingNCT07301203Phase 1

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative NeuralgiaEnrolling by invitationNCT07123402Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip ArthroplastyNot yet recruitingNCT07121101Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic SurgeryNot yet recruitingNCT07121023Phase 1

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.RecruitingNCT05970016Phase 1/2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• A Phase Ib/II Clinical Study in Patients With Refractory Chronic CoughNot yet recruitingNCT06213363Phase 1/2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• A Clinical Trial on the Treatment of Idiopathic Pulmonary FibrosisNot yet recruitingNCT06102083Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal SurgeryNot yet recruitingNCT05950152Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))Active, not recruitingNCT06169722Phase 1/2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy VolunteersCompletedNCT07123428Phase 1

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group

• Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion InjuryStatus unknownNCT03995732Phase 2

  Sponsor listed in the registry: Beijing Tide Pharmaceutical Co., Ltd · Beijing Tide Pharmaceutical Co., Ltd — acquired company within the Sino Biopharmaceutical Limited group